@inkblue01 No, I mean examples like this: "Post-exposure prophylaxis against SARS-CoV-2" https://t.co/NVhg8dgdfX "Harnessing safe, existing drugs such as LPV/r as PEP could provide an important tool for control of the COVID-19 pandemic."
@inkblue01 And this: "Post-exposure prophylaxis against SARS-CoV-2" https://t.co/NVhg8dgdfX "Harnessing safe, existing drugs such as LPV/r as PEP could provide an important tool for control of the COVID-19 pandemic."
@clairlemon It’s a post-exposure prophylaxis study. If they test positive or are exposed to a person with the virus and are presymptomatic, the study is set up to see if treatment will prevent them from progressing to full-blown disease. An example: ht
😷 Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial - BMC Blogs Network 👉 https://t.co/AopmSBXocT 💊 #Medical #GroupZirigoza